起订量:
ICG IR-825, CAS: 1558079-49-4,ICG吲哚菁绿
初级会员第7年
生产厂家陕西新研博美生物科技有限公司由多年从事生命科学领域的博士、研究生及试剂营销人士共同创立,我公司已经与国内外多家较有名的试剂供应商建立了长期稳定的合作关系,客户遍布中国生命科学基础研究、开发应用、疾病诊断与控制、商品检验检疫、生物技术、药物研发等诸多领域。
依靠*的化学合成技术和制造能力推出的聚乙二醇PEG生化试剂和聚乙二醇共聚物已达3000多种,其产品30多个国家和地区,已被近千名客户广泛使用并发表大量文章,简化便捷的采购方案和充足丰富的产品库存赢得客户的信赖。我们期待您的合作与推荐!
陕西新研博美生物科技有限公司
IR-825, CAS: 1558079-49-4,ICG吲哚菁绿
英文名:3-[(4-Carboxyphenyl)methyl]-2-[2-[3-[2-[3-[(4-carboxyphenyl)methyl]-1,3-dihydro-1,1-dimethyl-2H-benz[e]indol-2-ylidene]ethylidene]-2-chloro-1-cyclohexen-1-yl]ethenyl]-1,1-dimethyl-1H-benz[e]indolium
产品名称:3-[(4-羧基苯基)甲基]-2-[2-[3-[2-[3-[(4-羧基苯基)甲基]-1,3-二氢-1,1-二甲基-2H-苯并[e]吲哚-2-亚基]亚乙基]-2-氯-1-环己烯-1-基]乙烯基]-1,1-二甲基-1H-苯并[e]吲哚鎓
分子式:C54H48ClN2O4
分子量:824.42
CAS:1558079-49-4
结构式:
IR-825, CAS: 1558079-49-4,ICG吲哚菁绿
IR-825, after encapsulated into nanoparticles may be useful for cancer photothermal and photodynamic therapy. IR-825 nanoparticles showed pH-dependent fluorescence emission and excellent near-infrared (NIR) irradiation of cancer cells targeted in vitro to provide cytotoxicity. IR-825 nanoparticles showed efficient tumor homing together with rapid renal excretion behaviors, as revealed by MR imaging and confirmed by biodistribution measurement. Notably, when irradiated with an 808 nm laser, tumors on mice with IR-825 nanoparticle injection are compley eliminated without recurrence within 60 days, demonstrating the high efficacy of photothermal therapy.